| Peer-Reviewed

Implication of the Cytochrome P-450c17α (CYP17α) Gene in the Tumor Progression of Uterine Fibroids in Senegalese Women

Received: 20 September 2021     Accepted: 14 October 2021     Published: 28 October 2021
Views:       Downloads:
Abstract

Uterine fibroids, also known as leiomyomas, uterine myomas or fibroleiomyomas, are benign, encapsulated uterine tumors consisting of smooth muscle fibers of the uterus and connective tissue, the most common in the female genital tract. They affect 20 to 25% of women of childbearing age and are 3 to 9 times more common in black women than in white women, and nearly 70% of those close to 50 years of age. Uterine myomas are a real public health problem. The cost of treating them is expensive and the only treatment deemed effective is surgery. The rapid progression of leiomyomas during the childbearing years and regression after menopause indicate that estrogen plays a key role as a growth factor for these tumors. To contribute to the knowledge of the etiological factors involved in the tumor process of uterine fibroids, the study of the Cytochrome P-450c17α gene (CYP17α), involved in the hydroxylation of estrogen, has been carried out. Our study population consisted of 57 patients with uterine fibroids. After sampling (tumour tissue and peripheral blood), molecular analysis were done (DNA extraction, PCR-sequencing). Raw data were submitted to Mutation Surveyor 5.0.1 for mutation identification and AlamutVisual 2.12 software. The pathogenicity of each non-synonymous mutation was evaluated using Polyphen-2, Mutation Taster and SIFT. After cleaning, correction and alignment of sequences with BioEdit 7.0.8.0, genetic diversity, genetic differentiation and polymorphism of the gene CYP17α in correlation with epidemiological factors were determined with DNASP 5.10.01, MEGA 7.0.14, Arlequin 3.5.3.1 and the statistical software RStudio 3.5.1. Our results showed 84 mutations characterizing a high rate of tumor tissue polymorphism but also a genetic difference between tumor and peripheral blood. The mutation c.-34T>C which is located in the 5' promoter region at 34 bp upstream of the translation initiation site was found in patients with uterine fibroids. No genetic structuring of the CYP17α gene according to clinico-pathological parameters was observed. In conclusion, the cytochrome P450 enzymes responsible for highly specific reactions in the steroid biosynthesis pathway are gaining interest as molecular targets, given their role clé́ in the formation of various very potent endogenous steroid hormones. Indeed, current treatments for tumors, particularly fibroids, are mainly surgical and expensive. It is therefore essential to develop and evaluate alternatives to surgical procedures.

Published in International Journal of Genetics and Genomics (Volume 9, Issue 4)
DOI 10.11648/j.ijgg.20210904.12
Page(s) 67-77
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Leiomyoma Uterine, Cytochrome P-450c17α (CYP17α), Senegalese Patients

References
[1] Wathie F. K., 2007. Uterine fibroids at the Roi Baudouin health center in Guédiawaye: about 148 operated cases, Medical thesis. FMPOS: UCAD - Dakar, 188p.
[2] Bernard P., 2002. Uterine fibromyomas, Corpus Médical-Faculté de Médecine de Grenoble: Université Joseph Fourier.
[3] Baird D. D., Dunson D. B., Hill M. C., Cousins D., Schectman J. M., 2003. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence, Am. J. Obstet. Gynecol.; 188: 100–107.
[4] Chalal N., Demmouche A., 2013. Epidemiological profile of uterine fibroids in the region of Sidi Bel Abbes, Algeria. Pan African Medical Journal; 1-8.
[5] Eltoukhi H. M., Modi M. N., Weston M., Armstrong A. Y., Stewart E. A., 2014. The Health Disparities of Uterine Fibroids for African American Women: A Public Health Issue, Am. J. Obstet. Gynecol.; 210 (3): 194–199.
[6] Sparic R., M. D., Ljiljana Mirkovic, Ph.D., Antonio Malvasi, M. D., Andrea Tinelli, Ph.D., 2014. Epidemiology of Uterine Myomas A Review, Int J Fertil Steril. 2016; 9 (4): 424-435.
[7] Lamien A., 2009. Uterine leiomymes: Anatomopathological aspects and impact on the endometrium and ovarian hormones, Diploma of Advanced Study (D.E.A) UCAD - Dakar, 72p.
[8] Sall, 2017. Management of uterine fibroids at the National Hospital of Pikine concerning 419 operated cases, Thesis Medicine. STATE DIPLOMA: UCAD - Dakar, 100p.
[9] Catherino W. H., Eltoukhi H. M., Al-Hendy A., 2013. Racial and Ethnic Differences in the Pathogenesis and Clinical Manifestations of Uterine Leiomyoma, Seminars in Reproductive Medicine; 31 (5): 370–379.
[10] Kénémé B., 2020. Uterine Fibroids And Breast Adenofibroids: Epidemiology And Impacts Of Genetic Mutations On Their Developmental Physiology, Unique Doctoral Thesis: UCAD-Dakar, 177p.
[11] Ndime F, 2020. Penetrance of the p53 gene in uterine fibroids in Senegalese women, Master's thesis in Animal Biology: UCAD-Dakar, 36p.
[12] Hall T. A., 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids. Symp. Ser. 41: 95-98.
[13] Thompson J. D., Higgins D. G., Gibson T. J., 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Research; 22 (22): 4673-4680.
[14] Librado P., Rozas J., 2009. DnaSP version 5: a software for comprehensive analysis of DNA polymorphism data, Bioinfor.; 25: 1451-1452.
[15] Tamura K., Stecher G., Peterson D., Filipski A., and Kumar S., 2016. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol. Biol. Evol; 30: 2725-2729.
[16] R Development Core Team, "R: A language and environment for statistical computing", R Foundation for Statistical Computing, Vienna, Austria., 2005.
[17] Excoffier L., Laval G., Schneider S., 2010. Arlequin version 3.1: An integrated software package for population genetics data analysis, Evol. Bioinform. Online; 1: 45-50.
[18] Mäkinen N., Heinonen H., Moore S., Tomlinson I., Spuy Z., Aaltonen L., 2011. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget; (2): 966-969.
[19] Kénémé B., Ciss D., Ka S., Mbaye F., Dem., Sembène M., 2018. Uterine Fibroids in Senegal: Polymorphism of MED12 Gene and Correlation With Epidemiological Factors, American Journal of Cancer Research and Reviews; 2 (4): 1-16.
[20] Nakajin S., Hall P. F., 1981. Microsomal cytochrome P450 from neonatal pig testis. Purification and properties of a C21 steroid side-chain cleavage system (17α-hydroxylase-C17,20 lyase). Journal of Biological Chemistry; 256: 3871-3876.
[21] Nakajin S., Takahashi M., Shinoda M., and Hall, P. F., 1985. Cytochrome b5 promotes the synthesis of delta 16-C19 steroids by homogeneous cytochrome P-450 C21 side-chain cleavage from pig testis. Biochemical & Biophysical Research Communications; 132 (2): 708-713.
[22] Zachmann M., Vollmin J. A., Hamilton W., Prader A., 1972. Clinical Endocrinology; 1: 369- 385.
[23] Goebelsmann U., Zachmann M., Davajan V., Israel R., Mestman J. H., Mishell D. R., 1976. Gynecology Investigation; 7: 138-156.
[24] Sasano H., Okamoto M., Mason J. I., Simpson E. R., Mendelson C. R., Sasano N., Silverberg S. G., 1989. Immunolocalization of aromatase, 17 alphahydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. Journal of Reproduction and Fertility; 85: 163-169.
[25] Hanukoglu I., 1992. Steroidogenic enzymes-structure, function, and role in regulation of steroidhormone biosynthesis. Journal of Steroid Biochemistry and Molecular Biology; 43: 779-804.
[26] Puche C., Jose M., Cabero A., Meseguer A., 2002. Expression and enzymatic activity of the P450c17 gene in human adipose tissue. European Journal of Endocrinology; 146: 223-229.
[27] Akey J. M., Zhang G., Zhang K., Jin L., Shriver M. D., 2002. Interrogating a high-density SNP map for signatures of natural selection. Genome Research; 12: 1805-1814.
[28] Auchus R. J., 2001. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinology & Metabolism Clinics of North America; 30: 101-119.
[29] Wickenheisser J. K., Quinn P. G., Nelson V. L., Legro R. S., Strauss J. F., McAllister J. M., 2000. Differential activity of the cytochrome P450 17-alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. Journal of Clinical Endocrinology & Metabolism; 85: 2304-2311.
[30] Carey A. H., Dawn Waterworth., Kirty Patel., Davinia White., Julie Little., Patricia Novelli., Stephen Franks., Robert Williamson., 1994. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17, Human Molecular Genetics; 3 (10): 1873-1876.
[31] Sharp L., Cardy A. H., Cotton S. C., Little J., 2004. CYP17 gene polymorphisms: prevalence and associations with hormone levels and associated factors. Am. J. Epidemiol; 160 (8): 729–740.
[32] Li T. C., Tuckerman E. M., Laird S. M., 2002. Endometrial factors in recurrent miscarriage. Human Reproductive Update; 8: 43-52.
[33] Sata F., H. Yamada., A. Yamada., E. H. Kato., S. Kataoka., Y. Saijo., T. Kondo., J. Tamaki., H. Minakami., R. Kishi., 2003. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss, Molecular Human Reproduction; 9 (11): 725-728.
[34] Amant F., Dorfling C. M., de Brabanter J., Vandewalle J., Vergote I., Lindeque B. G., 2004. A possible role of the cytochrome P450-c17α gene (CYP17α) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. Acta Obstet. Gynecol. Scand.; 83: 234– 239.
[35] Vieira L. C. E., Gomes M. T. V., Castro R. A., de Souza N. C. N., da Silva I. D. C. G., Baracat E. C., 2008. Association of CYP17 gene polymorphism with risk of uterine leiomyoma in Brazilian women, Gynecol. Endocrinol.; 24 (7): 373–377.
[36] Alleyne A. T., Austin S., Williams A., 2014. Distribution of CYP17α polymorphism and selected physiochemical factors of uterine leiomyoma in Barbados, Met. Gene; 2: 358–365.
[37] Müssig K., Kaltenbach S., Machicao F., Maser-Gluth C., Hartmann M. F., Wudy S. A., Schnauder G., Haring H. U., Seif F. J., Gallwitz B., 2005. 17α hydroxylase/17,20 lyase defiency caused by a novel homozygous mutation (Y27stop) in the cytochrome CYP17 gene. The Journal of Clinical Endocrinology & Metabolism; 90 (7): 4362-4365.
[38] Hyder S. M., Huang J. C., Nawaz Z., Boettger-Tong H., Makela S., Chiappetta C., Stancel G. M., 2000. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environmental Health Perspectives; 108: 785-790.
[39] Wu X., Serna V. A, Thomas J., Qiang W., Blumenfeld M. L., Kurita T., 2017. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma. Cancer Research; 77 (24): 1-11.
[40] Yamane T., Inoue Y., Kobayashi-Hattori K., Oishi Y., 2016. Effects of an Amino acid Deficiency on Hyaluronan Synthesis in Human Dermal Fibroblasts, Food Science and Technology Research; 22 (2): 279-281.
[41] Moro J., Tomé D., Schmidely P., Demersay T. C., Azzout-Marniche D., 2020. Histidine: A Systematic Review on Metabolism and Physiological Effects in Human and Different Animal Species, MDPO; 12: 1-20.
[42] Pedroso A. B. J., Zampieri T. T., Donato J., 2015. Reviewing the Effects of L-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis, ISSN; 7: 3914-3937.
[43] Lim J. M., Kim G., Rodney L., Levine R. L., 2019. Methionine in Proteins: It’s Not Just for Protein Initiation Anymore, Neurochemical Research; 44: 247–257.
[44] Kim J. J., Kurita T., Bulun S. E., 2013. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocrinology Reviews; 34: 130-162.
[45] Moravek M. B., Yin P., Ono M., Coon J. St., Dyson M. T., Navarro A., Marsh E. E., Chakravarti D., Kim J. J., Wei J. J. 2015. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. Human Reproduction Updates; 21: 1-12.
[46] Andersen J., Dyreyes V. M., Barbieri R. L., Coachman D. M., Miksicek R. J., 1995. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures. Journal of the Society for Gynecologic Investigation; 2: 542-551.
[47] Pedeutour F., Quade B. J., Weremowicz S., Dal Cin P., Ali S., Morton C. C., 1998. Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata. Genes Chromosomes Cancer; 23: 361-366.
[48] Yin X. J., Wang G., Khan-Dawood F. S., 2007. Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyomaand myometrium-derived cell lines. American Journal of Obstetrics and Gynecology; 196 (176): 171-175.
[49] Kim J. J., Sefton E. C., 2012. The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Molecular and Cellular Endocrinology; 358: 223-231.
[50] Ishikawa H., Ishi K., Serna V. A., Kakazu R., Bulun S. E., Kurita T., 2010. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology; 151: 2433-2442.
[51] Hanahan D., Coussens L. M., 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell; 21: 309-322.
Cite This Article
  • APA Style

    Diallo Mariama, Ciss Daouda, Keneme Bineta, Gaye Alfousseyni, Sembene Pape Mbacke. (2021). Implication of the Cytochrome P-450c17α (CYP17α) Gene in the Tumor Progression of Uterine Fibroids in Senegalese Women. International Journal of Genetics and Genomics, 9(4), 67-77. https://doi.org/10.11648/j.ijgg.20210904.12

    Copy | Download

    ACS Style

    Diallo Mariama; Ciss Daouda; Keneme Bineta; Gaye Alfousseyni; Sembene Pape Mbacke. Implication of the Cytochrome P-450c17α (CYP17α) Gene in the Tumor Progression of Uterine Fibroids in Senegalese Women. Int. J. Genet. Genomics 2021, 9(4), 67-77. doi: 10.11648/j.ijgg.20210904.12

    Copy | Download

    AMA Style

    Diallo Mariama, Ciss Daouda, Keneme Bineta, Gaye Alfousseyni, Sembene Pape Mbacke. Implication of the Cytochrome P-450c17α (CYP17α) Gene in the Tumor Progression of Uterine Fibroids in Senegalese Women. Int J Genet Genomics. 2021;9(4):67-77. doi: 10.11648/j.ijgg.20210904.12

    Copy | Download

  • @article{10.11648/j.ijgg.20210904.12,
      author = {Diallo Mariama and Ciss Daouda and Keneme Bineta and Gaye Alfousseyni and Sembene Pape Mbacke},
      title = {Implication of the Cytochrome P-450c17α (CYP17α) Gene in the Tumor Progression of Uterine Fibroids in Senegalese Women},
      journal = {International Journal of Genetics and Genomics},
      volume = {9},
      number = {4},
      pages = {67-77},
      doi = {10.11648/j.ijgg.20210904.12},
      url = {https://doi.org/10.11648/j.ijgg.20210904.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijgg.20210904.12},
      abstract = {Uterine fibroids, also known as leiomyomas, uterine myomas or fibroleiomyomas, are benign, encapsulated uterine tumors consisting of smooth muscle fibers of the uterus and connective tissue, the most common in the female genital tract. They affect 20 to 25% of women of childbearing age and are 3 to 9 times more common in black women than in white women, and nearly 70% of those close to 50 years of age. Uterine myomas are a real public health problem. The cost of treating them is expensive and the only treatment deemed effective is surgery. The rapid progression of leiomyomas during the childbearing years and regression after menopause indicate that estrogen plays a key role as a growth factor for these tumors. To contribute to the knowledge of the etiological factors involved in the tumor process of uterine fibroids, the study of the Cytochrome P-450c17α gene (CYP17α), involved in the hydroxylation of estrogen, has been carried out. Our study population consisted of 57 patients with uterine fibroids. After sampling (tumour tissue and peripheral blood), molecular analysis were done (DNA extraction, PCR-sequencing). Raw data were submitted to Mutation Surveyor 5.0.1 for mutation identification and AlamutVisual 2.12 software. The pathogenicity of each non-synonymous mutation was evaluated using Polyphen-2, Mutation Taster and SIFT. After cleaning, correction and alignment of sequences with BioEdit 7.0.8.0, genetic diversity, genetic differentiation and polymorphism of the gene CYP17α in correlation with epidemiological factors were determined with DNASP 5.10.01, MEGA 7.0.14, Arlequin 3.5.3.1 and the statistical software RStudio 3.5.1. Our results showed 84 mutations characterizing a high rate of tumor tissue polymorphism but also a genetic difference between tumor and peripheral blood. The mutation c.-34T>C which is located in the 5' promoter region at 34 bp upstream of the translation initiation site was found in patients with uterine fibroids. No genetic structuring of the CYP17α gene according to clinico-pathological parameters was observed. In conclusion, the cytochrome P450 enzymes responsible for highly specific reactions in the steroid biosynthesis pathway are gaining interest as molecular targets, given their role clé́ in the formation of various very potent endogenous steroid hormones. Indeed, current treatments for tumors, particularly fibroids, are mainly surgical and expensive. It is therefore essential to develop and evaluate alternatives to surgical procedures.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Implication of the Cytochrome P-450c17α (CYP17α) Gene in the Tumor Progression of Uterine Fibroids in Senegalese Women
    AU  - Diallo Mariama
    AU  - Ciss Daouda
    AU  - Keneme Bineta
    AU  - Gaye Alfousseyni
    AU  - Sembene Pape Mbacke
    Y1  - 2021/10/28
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ijgg.20210904.12
    DO  - 10.11648/j.ijgg.20210904.12
    T2  - International Journal of Genetics and Genomics
    JF  - International Journal of Genetics and Genomics
    JO  - International Journal of Genetics and Genomics
    SP  - 67
    EP  - 77
    PB  - Science Publishing Group
    SN  - 2376-7359
    UR  - https://doi.org/10.11648/j.ijgg.20210904.12
    AB  - Uterine fibroids, also known as leiomyomas, uterine myomas or fibroleiomyomas, are benign, encapsulated uterine tumors consisting of smooth muscle fibers of the uterus and connective tissue, the most common in the female genital tract. They affect 20 to 25% of women of childbearing age and are 3 to 9 times more common in black women than in white women, and nearly 70% of those close to 50 years of age. Uterine myomas are a real public health problem. The cost of treating them is expensive and the only treatment deemed effective is surgery. The rapid progression of leiomyomas during the childbearing years and regression after menopause indicate that estrogen plays a key role as a growth factor for these tumors. To contribute to the knowledge of the etiological factors involved in the tumor process of uterine fibroids, the study of the Cytochrome P-450c17α gene (CYP17α), involved in the hydroxylation of estrogen, has been carried out. Our study population consisted of 57 patients with uterine fibroids. After sampling (tumour tissue and peripheral blood), molecular analysis were done (DNA extraction, PCR-sequencing). Raw data were submitted to Mutation Surveyor 5.0.1 for mutation identification and AlamutVisual 2.12 software. The pathogenicity of each non-synonymous mutation was evaluated using Polyphen-2, Mutation Taster and SIFT. After cleaning, correction and alignment of sequences with BioEdit 7.0.8.0, genetic diversity, genetic differentiation and polymorphism of the gene CYP17α in correlation with epidemiological factors were determined with DNASP 5.10.01, MEGA 7.0.14, Arlequin 3.5.3.1 and the statistical software RStudio 3.5.1. Our results showed 84 mutations characterizing a high rate of tumor tissue polymorphism but also a genetic difference between tumor and peripheral blood. The mutation c.-34T>C which is located in the 5' promoter region at 34 bp upstream of the translation initiation site was found in patients with uterine fibroids. No genetic structuring of the CYP17α gene according to clinico-pathological parameters was observed. In conclusion, the cytochrome P450 enzymes responsible for highly specific reactions in the steroid biosynthesis pathway are gaining interest as molecular targets, given their role clé́ in the formation of various very potent endogenous steroid hormones. Indeed, current treatments for tumors, particularly fibroids, are mainly surgical and expensive. It is therefore essential to develop and evaluate alternatives to surgical procedures.
    VL  - 9
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Department of Animal Biology, Faculty of Science and Technology, University Cheikh Anta Diop of Dakar, Dakar, Senegal

  • Maternity and Gynecology Obstetrics Service, Idrissa Pouye Hospital, Dakar, Senegal

  • Department of Animal Biology, Faculty of Science and Technology, University Cheikh Anta Diop of Dakar, Dakar, Senegal

  • Maternity and Gynecology Obstetrics Service, Idrissa Pouye Hospital, Dakar, Senegal

  • Department of Animal Biology, Faculty of Science and Technology, University Cheikh Anta Diop of Dakar, Dakar, Senegal

  • Sections